Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG (NOVN)

174
Delayed Quote. Delayed BATS Europe - 10/31 04:09:56 am
88.775 CHF   +1.23%
2d ago NOVARTIS : Psoriasis is so much more than a skin disease and has effects on..
2d agoDJNorway's Oil Fund Posts Flat Returns in 3Q
2d agoDJNorway's Oil Fund Posts Flat Returns in 3Q--Update
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on NOVARTIS AG
10/09 VECTURA : Partner Gets Approval For AirFluSal Forspiro In Portugal
10/09 NOVARTIS : Beckman Coulter Webinar Shows How to Set Up Aggregation Analysis to A..
10/09 NOVARTIS : New data on the global economic impact and burden of preventable blin..
10/09 NOVARTIS : New data on the global economic impact and burden of preventable blin..
10/09 NOVARTIS : New data on the global economic impact and burden of preventable blin..
10/08 NOVARTIS : Patent Issued for Method of Treating Middle Ear Infections
10/08 INCYTE : Earns $60 Million Milestone Related to Reimbursement of Jakavi® ruxolit..
10/08 Cynapsus Therapeutics Announces Hiring Of New Chief Scientific Officer And EV..
10/08 TEARLAB : Julie Speed Joins TearLab as Vice President, Global Marketing
10/08 NOVARTIS : Shareholder group critical as Roche and Novartis chiefs top Swiss pay..
10/08 NOVARTIS : (Pr)Lucentis® (ranibizumab) approved by Health Canada to treat vision..
10/08 Novartis says three executives to leave after GSK, Lilly deals
10/08 NOVARTIS : Changes to the Novartis Executive Committee after expected completion..
10/08 NOVARTIS : Changes to the Novartis Executive Committee after expected completion..
10/07 Drugmaker GSK investigating corruption allegations in UAE
10/07 Biotech Science News Announces the Top 10 Pharmaceutical Companies Presenting..
10/07 NOVARTIS : Alcon Research Assigned Patent
10/07 INCYTE : Garners Payment Related to Reimbursement of Jakavi (ruxolitinib)
10/06 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
10/06 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
10/06 NOVARTIS : ABPI members win prestigious Prix Galien awards
10/06 NOVARTIS : announces clinical collaboration to evaluate Bristol-Myers Squibb's n..
10/06 NOVARTIS : announces clinical collaboration to evaluate Bristol-Myers Squibb's n..
10/04 NOVARTIS : ABPI Members Win Prestigious Prix Galien Awards
10/04 ELI LILLY : Mergers: Commission Approves Acquisition of Novartis Animal Health D..
10/04 NOVARTIS : Patent Issued for Kit for Topical Application of Medication
10/03 NOVARTIS : "Handheld Ocular Aspiration Tool" in Patent Application Approval Proc..
10/03 PROVECTUS BIOPHARMACEUTICALS : Appoints Christopher Kaplan to Its Strategic Advi..
10/03DJNOVARTIS : EU Approves Acquisition of Novartis Animal Health Division by Eli Lil..
10/03 ELI LILLY : EU OKs Eli Lilly's $5.4B bid for Novartis division
10/03 EU Commission clears Eli Lilly, Novartis deal
10/03DJNOVARTIS : EU Approves Acquisition of Novartis Animal Health Division by Eli Lil..
10/02 EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal - sources
10/02 NOVARTIS : announces Skin Impressions campaign launch on the first International..
10/02 NOVARTIS : to tackle climate change with Sichuan tree planting project
10/01 NOVARTIS : to face US legal action
10/01 NESTLERFD : VGK, EFO: Big ETF Outflows
10/01 NOVARTIS : SDNY Denies Novartis' Motion to Dismiss Kickback Lawsuit Under False ..
10/01 NOVARTIS : reports 3,878 suspected cases of drug side effects
10/01 NOVARTIS : announces Skin Impressions campaign launch on the first International..
10/01 NOVARTIS : Reports Results on Overall Survival from Phase III of Afinitor
10/01 Plant-based vaccines challenge big pharma for $3 billion flu market
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
10/01 NOVARTIS : showcases dermatology leadership on International Urticaria Day annou..
09/30 NESTLERFD : VEU, SRTY: Big ETF Inflows
09/30 NOVARTIS : Alcon Research Assigned Patent
09/29 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/29 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
09/29 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/29 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/29 NOVARTIS : drug Signifor LAR recommended by CHMP for EU approval to treat patien..
09/28 NOVARTIS : Eye Surgery Equipment Sought by Veterans Affairs
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : Patients lived average of 18 months without cancer progressing when t..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/27 NOVARTIS : drug Afinitor is first treatment for advanced pancreatic NET to provi..
09/26 NOVARTIS : Strewth! Cyclists clock-up two return trips to Oz ; When we asked you..
09/26 NOVARTIS : and the NHS work together to improve sight loss services for local pe..
09/26 NOVARTIS : Retroscreen Virology Group Announces Half -Year Financial Report
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/26 NOVARTIS : drug Signifor® LAR recommended by CHMP for EU approval to treat patie..
09/25 NOVARTIS : NAPSRx Investigates: New Heart Failure Drug Reduces Cardiovascular De..
09/25 NOVARTIS : NAD Recommends Alcon Discontinue Certain Claims for Air Optix Aqua Co..
09/25 GlaxoSmithKline appoints RBS's Hampton as next chairman
09/25DJGlaxo Names RBS's Hampton as Chairman
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/25 NOVARTIS : AIN457 (secukinumab) is the first ever IL-17A inhibitor to meet prima..
09/24 Adaptimmune raises $104 million to develop immune-system cancer drugs
09/23 NOVARTIS : Provectus Biopharmaceuticals Appoints Christopher Kaplan to Its Strat..
09/23 NOVARTIS : Alcon Research Assigned Patent
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF